Timely delivery of bone marrow mesenchymal stem cells based on the inflammatory pattern of bone injury environment to promote the repair of calvarial bone defects in rats: An optimized strategy for bone tissue engineering

被引:1
作者
Zeng, Yuwei [1 ,2 ]
Lou, Aiju [3 ]
Zhong, Zhenmin [4 ]
Cai, Yu [1 ]
Yang, Yixi [1 ]
Liang, Haifeng [1 ]
Lin, Yucong [1 ]
He, Zhuoxuan [1 ]
Zhou, Lei [1 ]
Zhang, Zhi-Yong [5 ]
Wang, Le [1 ,2 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Prov Clin Res Ctr Obstet & Gynecol, Guangzhou Key Lab Spine Dis Prevent & Treatment,Gu, 63 Duobao Rd, Guangzhou 510150, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Prov Clin Res Ctr Obstet & Gynecol, Dept Orthopaed Surg,Guangdong Prov Key Lab Major O, Guangzhou, Peoples R China
[3] Liwan Cent Hosp Guangzhou, Dept Rheumatol, Guangzhou, Peoples R China
[4] Guangzhou Med Univ, Huizhou Peoples Hosp 3, Orthopaed Noninvas Care Ctr, Huizhou, Peoples R China
[5] Guangzhou Med Univ, Affiliated Hosp 3, Translat Res Ctr Regenerat Med & 3D Printing, 63 Duobao Rd, Guangzhou 510150, Peoples R China
来源
JOURNAL OF TISSUE ENGINEERING | 2024年 / 15卷
基金
中国国家自然科学基金;
关键词
Bone tissue engineering strategy; bone marrow mesenchymal stem cells; calvarial bone defect; inflammation regulation; cell survival; STROMAL CELLS; IMMUNOLOGICAL-PROPERTIES; ANGIOGENESIS; REGENERATION; SURVIVAL; TRANSPLANTATION; OSTEOGENESIS; SCAFFOLDS; APOPTOSIS; GROWTH;
D O I
10.1177/20417314241252960
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Stem cell-based therapy plays a significant role in the repair of bone defects. However, traditional stem cell transplantation strategies in bone tissue engineering are characterized by low survival rates and unstable treatment outcomes. In this study, we propose a timely delivery strategy for inflammatory changes in the setting of bone injury to improve the survival rate of transplanted cells and bone repair. The results of cell tracing in vivo showed that this strategy could effectively improve the survival rate of low-dose exogenous transplanted cells in bone defect areas, and CD31 immunofluorescence and histological sections suggested that this strategy effectively promoted vascularization and new bone formation in the calvarial defect area. Subsequently, we analyzed the mechanism of action of the "Two-step" strategy from the perspective of inflammatory microenvironment regulation, and the results suggested that the first batch transplanted stem cells caused localized and transient increases in tissue apoptosis levels and inflammatory factors, and recruited macrophage chemotaxis, and the second batch of cells may promote pro-inflammatory - anti-inflammatory transformation of the tissue. Finally, mRNA sequencing results suggest that the first batch cells in the "Two-step" strategy are important initiators in bone repair, which not only actively regulate the immune microenvironment at the bone defect, but also guide richer cellular activity and more positive biochemical responses. Therefore, the "Two-step" strategy leads to efficient inflammatory environment regulation and superior bone repair effects, which may provide an alternative option for the treatment of bone defects in the future. Graphical abstract
引用
收藏
页数:20
相关论文
共 70 条
  • [1] Stem cell death and survival in heart regeneration and repair
    Abdelwahid, Eltyeb
    Kalvelyte, Audrone
    Stulpinas, Aurimas
    Teixeira de Carvalho, Katherine Athayde
    Guarita-Souza, Luiz Cesar
    Foldes, Gabor
    [J]. APOPTOSIS, 2016, 21 (03) : 252 - 268
  • [2] Immunomodulatory properties of human placental mesenchymal stem/stromal cells
    Abumaree, M. H.
    Abomaray, F. M.
    Alshabibi, M. A.
    AlAskar, A. S.
    Kalionis, B.
    [J]. PLACENTA, 2017, 59 : 87 - 95
  • [3] Human Macrophage Regulation Via Interaction With Cardiac Adipose Tissue-Derived Mesenchymal Stromal Cells
    Adutler-Lieber, Shimrit
    Ben-Mordechai, Tammar
    Naftali-Shani, Nili
    Asher, Elad
    Loberman, Dan
    Raanani, Ehud
    Leor, Jonathan
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 18 (01) : 78 - 86
  • [4] Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
  • [5] Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium - Feasibility, cell migration, and body distribution
    Barbash, IM
    Chouraqui, P
    Baron, J
    Feinberg, MS
    Etzion, S
    Tessone, A
    Miller, L
    Guetta, E
    Zipori, D
    Kedes, LH
    Kloner, RA
    Leor, J
    [J]. CIRCULATION, 2003, 108 (07) : 863 - 868
  • [6] IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate
    Boland, Lauren
    Burand, Anthony J.
    Brown, Alex J.
    Boyt, Devlin
    Lira, Vitor A.
    Ankrum, James A.
    [J]. MOLECULAR THERAPY, 2018, 26 (03) : 860 - 873
  • [7] Apoptosis in bone for tissue engineering
    Bran, Gregor M.
    Stern-Straeter, Jens
    Hoermann, Karl
    Riedel, Frank
    Goessler, Ulrich R.
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2008, 39 (05) : 467 - 482
  • [8] Control of crosslinking for tailoring collagen-based scaffolds stability and mechanics
    Davidenko, N.
    Schuster, C. F.
    Bax, D. V.
    Raynal, N.
    Farndale, R. W.
    Best, S. M.
    Cameron, R. E.
    [J]. ACTA BIOMATERIALIA, 2015, 25 : 131 - 142
  • [9] Current understanding of the immunosuppressive properties of mesenchymal stromal cells
    de Castro, Ligia Lins
    Lopes-Pacheco, Miqueias
    Weiss, Daniel Jay
    Cruz, Fernanda Ferreira
    Macedo Rocco, Patricia Rieken
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2019, 97 (05): : 605 - 618
  • [10] Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts
    Don, Creighton W.
    Murry, Charles E.
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2013, 17 (11) : 1355 - 1362